Dexcom G6 applicator
Continuous Glucose Monitors (CGMs) are one of the most powerful diabetes management tools developed over the past few decades.
The FDA approved the...
Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...